Harmony Biosciences's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Harmony Biosciences (NASDAQ:HRMY) is set to release its latest quarterly earnings report on August 1, 2023. Analysts estimate an earnings per share (EPS) of $0.62. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. However, the stock has been down 36.18% over the last 52-week period.
July 31, 2023 | 9:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Harmony Biosciences is expected to report an EPS of $0.62 for the upcoming quarter. The company has a history of beating EPS estimates, which could potentially lead to a short-term increase in share price. However, the stock has been down 36.18% over the last 52 weeks.
The company's history of beating EPS estimates could potentially lead to a short-term increase in share price following the earnings report. However, the overall negative trend in the stock's performance over the past year may dampen investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100